Firstly, the chosen population in the present study allowed us to investigate the role of adiponectin in obesity-hypertension axis in a relatively homogeneous and early-stage group, without the confounding effects of medication or other comorbidities. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.